
Health
Merck and Moderna report lower risk of melanoma recurrence or death
Oxford associate professor in October 2026 who discussed the trial's safety findings and disclosed cancer-vaccine research roles.

Oxford associate professor in October 2026 who discussed the trial's safety findings and disclosed cancer-vaccine research roles.